Loading organizations...
§ Venture Capital · Seattle, WA, USA
Healthcare venture capital firm investing in biotech startups developing cures, preventions, and treatments for unsolved diseases.
Key people at Discover Ventures.
Discover Ventures is a Wilmington, Delaware-based healthcare-focused venture capital firm that invests in biotechnology startups developing novel cures, preventions, and treatments for unsolved diseases. The firm provides critical capital for early-stage scientific technologies, specifically targeting emerging companies operating within the complex drug discovery, gene therapy, cell therapy, and neurodegeneration sectors. Operating with an estimated annual revenue of under $5 million, the organization currently maintains a dedicated workforce of 11 to 50 employees to evaluate and support its investments. The firm leverages the extensive clinical and entrepreneurial expertise of its core leadership team, whose members have previously founded or directed notable biotechnology enterprises such as Pixium Vision, GenSight Biologics, Fovea Pharmaceuticals, and Orchard Therapeutics. Discover Ventures was established in an undisclosed year and is currently led by its key partners Guillen Lopez, Serge Picaud, and Andrea Spezzi.
Key people at Discover Ventures.
Discovery Ventures is a Berlin-based early-stage venture capital firm focused on investing in Fintech, B2B SaaS, and Artificial Intelligence startups, primarily at the pre-seed and seed stages with initial investments ranging from €200k to €1 million[1][3]. The firm’s mission centers on leveraging the operational experience of its partners—who have scaled businesses from ideation to pre-IPO—to support exceptional founders worldwide. Their investment philosophy emphasizes active engagement and co-investment alongside leading global VC firms, aiming to accelerate growth and innovation in their core sectors[1]. Discovery Ventures plays a significant role in the startup ecosystem by providing not only capital but also hands-on support, helping early-stage companies navigate critical growth phases.
Founded by experienced operators turned investors, including founding partners Dr. Jan Deepen and Mr. Stefan Jeschonnek, Discovery Ventures emerged from a decade of scaling technology businesses[1][3]. The firm’s evolution reflects a transition from building companies to reinvesting knowledge and capital into promising startups, particularly in fintech and AI. Their Berlin base situates them at the heart of Europe’s growing tech scene, allowing them to tap into a vibrant ecosystem while maintaining global investment ambitions[3].
Discovery Ventures rides the wave of digital transformation in financial services, enterprise software, and AI-driven innovation. The timing is favorable due to increasing demand for seamless fintech solutions, AI integration in business processes, and scalable SaaS platforms. Market forces such as regulatory changes, digital adoption by SMBs, and AI advancements create fertile ground for startups Discovery Ventures backs. By focusing on early-stage companies, the firm influences the ecosystem by nurturing innovation at its inception, helping shape future market leaders in fintech and AI[1][3].
Looking ahead, Discovery Ventures is poised to deepen its impact by expanding investments in emerging sectors adjacent to fintech and AI, potentially increasing deal sizes as portfolio companies mature. Trends like AI democratization, embedded finance, and SaaS platform expansion will likely shape their investment focus. Their operator-led approach and global syndication strategy position them well to identify and scale disruptive startups. As the startup ecosystem evolves, Discovery Ventures’ influence may grow from a micro fund to a key early-stage player bridging European innovation with global capital networks[1][3]. This trajectory ties back to their founding ethos of reinvesting operational experience to empower visionary founders worldwide.
